This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $108,945.23 firm fixed-price delivery order is for XELJANZ XR 11 MG TABLET UU 30S, with a completion date of November 7, 2024. The contract does not have a set-aside designation, indicating open competition.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, that covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Generated 2/5/25, 9:36 AM